Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
Surjit Singh, Pramod Kumar Sharma Department of Pharmacology, AIIMS, Jodhpur, Rajasthan, India
Correspondence Address:
Surjit Singh Department of Pharmacology, AIIMS, Jodhpur, Rajasthan India
Here, we present a case of chronic myeloid leukemia for which imatinib therapy was initated. Triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone was normal, and thyroid microsomal autoantibodies (TMA) were positive and patient was diagnosed as thyroiditis treated with corticosteroids for 1½ months which lead to resolution.
How to cite this article:
Singh S, Sharma PK. Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia.Indian J Pharmacol 2016;48:458-459
|
How to cite this URL:
Singh S, Sharma PK. Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia. Indian J Pharmacol [serial online] 2016 [cited 2023 Sep 30 ];48:458-459
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=4;spage=458;epage=459;aulast=Singh;type=0 |
|